Related Experiment Video
Updated: Sep 10, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Comorbidity and Multimorbidity in Adults With Congenital Heart Disease: Findings From a Multi-Site Population-Based
Lorenzo D Botto1, Matthew R Reeder1, George K Lui2
1Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA.
Insights
Adults with congenital heart disease (CHD) frequently develop multiple comorbidities, particularly endocrine, metabolic, and neuropsychiatric conditions. Understanding these patterns is crucial for improving lifelong care and preventing mortality in this growing population.
Area of Science:
- Cardiology
- Public Health
- Adult Congenital Heart Disease
Background:
- Improved survival in congenital heart disease (CHD) has led to a growing adult population.
- Adults with CHD face numerous comorbidities impacting outcomes and care.
- Population-based data on comorbidities in adults with CHD are limited, hindering prevention efforts.
Purpose of the Study:
- To assess the prevalence and patterns of comorbid conditions in adults with congenital heart disease.
- To identify common cardiac and noncardiac comorbidities in this population.
- To explore variations in comorbidity burden based on sociodemographic factors.
Main Methods:
- A population-based, cross-sectional study of 18,672 adults (aged 19-64) with CHD in the US.
- Data from linked clinical and administrative sources (inpatient, outpatient, emergency department) between 2011-2013.
- Inclusion based on ≥1 CHD-related diagnosis code.
Main Results:
- A high prevalence of comorbidities was observed: 88.5% had at least one, and 76% had multiple.
- Noncardiac comorbidities were more frequent than cardiac ones, including endocrine/metabolic (diabetes, hyperlipidemia, hypothyroidism), hypertension, and neuropsychiatric conditions.
- Comorbidity rates varied by sociodemographics; men and older adults had higher rates, irrespective of CHD type.
Conclusions:
- Preventable comorbidities and multimorbidity are highly prevalent in adults with CHD.
- Comorbidity patterns are influenced by sociodemographic factors and CHD type.
- Lifelong, coordinated, data-driven care and health metric tracking are essential to reduce mortality.
Background:
Survival of individuals with congenital heart disease (CHD) has improved, leading to a growing and aging population of adults living with these conditions. Over their lifetime, they often face an array of comorbidities that affect outcomes and complicate medical management. However, population-based information on such comorbidities is scarce, reducing opportunities for prevention.
Methods:
This population-based, cross-sectional study assessed comorbid conditions in adults with CHD residing in five geographic areas in the United States (in Colorado, Georgia, New York, North Carolina, and Utah). The study included 18,672 adults aged 19 to 64 years who had a healthcare encounter between 2011 and 2013 associated with ≥ 1 CHD-related diagnosis code. Data were derived from linked clinical and administrative sources, reflecting inpatient, outpatient, and emergency department encounters.
Results:
Most adults with CHD experienced at least one (88.5%) and usually multiple (76%) comorbidities. Overall, noncardiac comorbidities exceeded cardiac comorbidities. The most frequent noncardiac comorbidities were endocrine/metabolic conditions (e.g., diabetes, hyperlipidemia, hypothyroidism), hypertension, and neuropsychiatric conditions (e.g., anxiety, depression). The presence and number of comorbidities varied in different sociodemographic groups. Men and older individuals experienced higher rates of many comorbidities, cardiac and noncardiac, regardless of CHD type.
Conclusions:
Preventable and treatable comorbidity and multimorbidity are common in adults with CHD, with patterns shaped by sociodemographic factors and CHD type. Reducing preventable mortality in this growing population will require sustained tracking of health metrics and coordinated, data-driven, and lifelong care.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Rheumatic Heart Disease I: Introduction
Heart Failure III: Clinical Manifestations
Heart Failure IV: Classification and Diagnostic Evaluation

